医药前沿
醫藥前沿
의약전연
YIAYAO QIANYAN
2014年
6期
219-220
,共2页
何江%张欣宁%许春雷%诸月妮
何江%張訢寧%許春雷%諸月妮
하강%장흔저%허춘뢰%제월니
氟比洛芬酯%曲马多%静脉镇痛%腹部手术
氟比洛芬酯%麯馬多%靜脈鎮痛%腹部手術
불비락분지%곡마다%정맥진통%복부수술
flurbiprofen axetil%tramadol%intravenous analgesia%abdominal operation
目的:观察氟比洛芬酯复合曲马多用于腹部手术患者持续静脉镇痛的有效性及安全性。方法选择ASA分级Ⅰ~Ⅱ级、择期行腹部手术的患者80例,随机分为氟比洛芬酯(F组)和曲马多组(T组),每组40例。F组首量为氟比洛芬酯50mg,镇痛泵内加入氟比洛芬酯200mg、曲马多400mg和托烷司烷5mg并用生理盐水稀释至100ml。T组首量为曲马多100mg,镇痛泵内加入曲马多800mg和托烷司琼5mg并用生理盐水稀释至l00ml。两组均设定相同的PCA参数(2ml/h,按压0.5ml/次,锁定时间15min)。于术后1,3,6,12,24和48h观察并记录患者各时点的VAS评分、统计术后48h内PCIA按压次数及不良反应。结果 F组与T组术后VAS评分及术后48h内按压次数差异无统计学意义,但不良反应存在差异,F组不良反应发生率明显低于T组。结论腹部手术患者持续静脉镇痛应用氟比洛芬酯复合曲马多静脉持续镇痛具有安全、效果确切及不良反应少的优点。
目的:觀察氟比洛芬酯複閤麯馬多用于腹部手術患者持續靜脈鎮痛的有效性及安全性。方法選擇ASA分級Ⅰ~Ⅱ級、擇期行腹部手術的患者80例,隨機分為氟比洛芬酯(F組)和麯馬多組(T組),每組40例。F組首量為氟比洛芬酯50mg,鎮痛泵內加入氟比洛芬酯200mg、麯馬多400mg和託烷司烷5mg併用生理鹽水稀釋至100ml。T組首量為麯馬多100mg,鎮痛泵內加入麯馬多800mg和託烷司瓊5mg併用生理鹽水稀釋至l00ml。兩組均設定相同的PCA參數(2ml/h,按壓0.5ml/次,鎖定時間15min)。于術後1,3,6,12,24和48h觀察併記錄患者各時點的VAS評分、統計術後48h內PCIA按壓次數及不良反應。結果 F組與T組術後VAS評分及術後48h內按壓次數差異無統計學意義,但不良反應存在差異,F組不良反應髮生率明顯低于T組。結論腹部手術患者持續靜脈鎮痛應用氟比洛芬酯複閤麯馬多靜脈持續鎮痛具有安全、效果確切及不良反應少的優點。
목적:관찰불비락분지복합곡마다용우복부수술환자지속정맥진통적유효성급안전성。방법선택ASA분급Ⅰ~Ⅱ급、택기행복부수술적환자80례,수궤분위불비락분지(F조)화곡마다조(T조),매조40례。F조수량위불비락분지50mg,진통빙내가입불비락분지200mg、곡마다400mg화탁완사완5mg병용생리염수희석지100ml。T조수량위곡마다100mg,진통빙내가입곡마다800mg화탁완사경5mg병용생리염수희석지l00ml。량조균설정상동적PCA삼수(2ml/h,안압0.5ml/차,쇄정시간15min)。우술후1,3,6,12,24화48h관찰병기록환자각시점적VAS평분、통계술후48h내PCIA안압차수급불량반응。결과 F조여T조술후VAS평분급술후48h내안압차수차이무통계학의의,단불량반응존재차이,F조불량반응발생솔명현저우T조。결론복부수술환자지속정맥진통응용불비락분지복합곡마다정맥지속진통구유안전、효과학절급불량반응소적우점。
Objective To observe the efficacy and safety of flurbiprofen axetil combined tramadol ,used for postoperative patient-control ed intravenous analgesia in patients undergoing abdominal surgeries. Methods: EightyⅠ ~ Ⅱlevel of ASA patients undergoing abdominal surgeries were enrol ed in this study. Patients were randomly divided into flurbiprofen group (group F) and tramadol group (group T), 40 cases in each group. The patients in Group F received flurbiprofen axetil 50mg as initial dose, the analgesia pump added with flurbiprofen axetil 200mg, tramadol 400mg and thromboxane 5mg and diluted with saline to 100ml. The initial dose in group T was tramadol 100mg, analgesia pump added with tramadol 800mg and 5mg tropisetron and diluted with saline to l00ml. The two groups were set with the same PCA parameter (2ml/h, per-press 0.5ml, lockout time of15min). After postoperation of 1h,3h,6h,12h,24h and 48h, observed the patients and recorded the VAS scores, and statistics of pressing times and adverse reaction after 48h PCIA. The results of postoperative VAS score and postoperative 48h press times have no significant difference in group F and group T, but there are differences in adverse reactions occurred. The adverse reaction rate in group F was dearly lower than that of group T. Conclusion The usage of combination of Flurbiprofen axetil with Tramadol used in patients undergoing abdominal surgeries in PCIA, can reduce adverse reactions, and get a satisfactory analgesic effect. It is a safe, effective, and convenient analgesic method.